Caroli disease
MeSH: D016767ORPHA: 530351 Treatment Available
Overview
bile duct disease that is characterized by abnormal dilatation of the intrahepatic bile ducts
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Ursodeoxycholic acid | Capsule, Tablet | FDA Approved | 6 | 3d |
Clinical Presentation
Signs and symptoms associated with Caroli disease, sourced from HPO and Orphanet clinical annotations.
CholestasisJaundiceIntrahepatic cholestasisAbdominal painConjugated hyperbilirubinemiaElevated circulating alkaline phosphatase concentrationCholangitisElevated gamma-glutamyltransferase levelPolycystic kidney dysplasiaPruritusCholelithiasisCirrhosisAscitesSplenomegalyWeight lossFeverIncreased total leukocyte countVomitingNauseaAnorexiaEsophageal varixHepatomegalyChillsElevated circulating alanine aminotransferase concentrationConjunctival icterusAbdominal rigidityHepatic fibrosisPortal hypertensionBiliary cirrhosisCholangiocarcinomaLiver abscess
Classification & Codes
MeSH Code
D016767Orphanet Code
ORPHA:53035Caroli disease
| MeSH | D016767 |
| Orphanet | ORPHA:53035 |
| Treatments | 1 drug(s) |
| Symptoms on record | 31 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO